398869001: Aspirin + caffeine + orphenadrine citrate (product)

Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2008. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

1766789012 Aspirin + caffeine + orphenadrine citrate (product) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

1778357013 Aspirin + caffeine + orphenadrine citrate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4232411000005112 acetylsalicylsyre + caffein + orphenadrincitrat da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
acetylsalicylsyre + caffein + orphenadrincitrat	Is a	Product containing caffeine (medicinal product)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	Is a	Product containing aspirin (medicinal product)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	Is a	orphenadrincitrat	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Orphenadrine (substance)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Xanthine	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Stimulant (substance)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Aspirin (substance)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Caffeine	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Bronchodilator (substance)	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Phosphodiesterase inhibitor	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Xanthine	false	Inferred relationship	Some
acetylsalicylsyre + caffein + orphenadrincitrat	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	Orphenadrine citrate (substance)	false	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
acetylsalicylsyre + caffein + orphenadrincitrat tablet	Is a	False	acetylsalicylsyre + caffein + orphenadrincitrat	Inferred relationship	Some

Reference Sets

Concept inactivation indicator reference set

POSSIBLY EQUIVALENT TO association reference set (foundation metadata concept)